Literature DB >> 11956090

Inhibition of radiation-induced nuclear factor-kappaB activation by an anti-Ras single-chain antibody fragment: lack of involvement in radiosensitization.

Jeffery S Russell1, Uma Raju, Glenice J Gumin, Fredrick F Lang, Deborah R Wilson, Thierry Huet, Philip J Tofilon.   

Abstract

We have shown previously that the transduction of a number of human tumor cell lines with an adenovirus (AV1Y28) expressing a single-chain antibody fragment (scFv) directed against Ras proteins results in radiosensitization. Because Ras is involved in the regulation of a number of transcription factors, we have determined the effects of this adenovirus on the activation of nuclear factor-kappaB (NF-kappaB), a radiation-responsive transcription factor associated with cell survival. In U251 human glioma cells, radiation-induced NF-kappaB was significantly attenuated by prior transduction of the anti-Ras scFv adenovirus. This effect appeared to involve an inhibition of IkappaB kinase activity and IkappaBalpha phosphorylation. Inhibitors to the Ras effectors mitogen-activated protein kinase kinase, phosphatidylinositol 3-kinase, and p38, however, did not reduce radiation-induced NF-kappaB. Whereas AV1Y28 inhibited NF-kappaB activation by hydrogen peroxide and ferricyanide, it had no effect of tumor necrosis factor-alpha-induced NF-kappaB activation. These results are consistent with a novel Ras-dependent, oxidant-specific signaling pathway mediating the activation of NF-kappaB. In additional cell lines radiosensitized by AV1Y28, radiation-induced NF-kappaB activation was also inhibited by the anti-Ras scFv, whereas in cell lines not radiosensitized, radiation did not activate NF-kappaB. This correlation suggested that AV1Y28-mediated radiosensitization involved the inhibition of radiation-induced NF-kappaB activation. However, inhibition of NF-kappaB activation via the expression of a dominant-negative form of IkappaBalpha in U251 cells had no effect on radiation-induced cell killing and did not influence AV1Y28-mediated radiosensitization. Therefore, whereas AV1Y28 inhibits radiation-induced NF-kappaB activation, this process does not appear to play a direct role in its radiosensitizing actions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956090

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Inhibition of cathepsin L sensitizes human glioma cells to ionizing radiation in vitro through NF-κB signaling pathway.

Authors:  Neng Yang; Pan Wang; Wen-juan Wang; Yun-zhen Song; Zhong-qin Liang
Journal:  Acta Pharmacol Sin       Date:  2015-02-09       Impact factor: 6.150

2.  Radiation-induced activation of nuclear factor-kappaB involves selective degradation of plasma membrane-associated I(kappa)B(alpha).

Authors:  Jeffery S Russell; Philip J Tofilon
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

3.  Matrix metalloproteinase-9 inhibition down-regulates radiation-induced nuclear factor-kappa B activity leading to apoptosis in breast tumors.

Authors:  Sateesh Kunigal; Sajani S Lakka; Pushpa Joseph; Norman Estes; Jasti S Rao
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

Review 4.  Molecular targets for tumor radiosensitization.

Authors:  Philip J Tofilon; Kevin Camphausen
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

Review 5.  Many faces of NF-kappaB signaling induced by genotoxic stress.

Authors:  Zhao-Hui Wu; Shigeki Miyamoto
Journal:  J Mol Med (Berl)       Date:  2007-07-03       Impact factor: 4.599

6.  Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells.

Authors:  Beatrice Bachmeier; Iduna Fichtner; Peter H Killian; Emanuel Kronski; Ulrich Pfeffer; Thomas Efferth
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.